CIK 0001178670
- Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770602661
- Phone
- +1 617-551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-25 | SHARP PHILLIP A Director | Sale | −15,715 | $125.05 | $2.0M | 238,395 |
| 2020-11-25 | SHARP PHILLIP A Director | Sale | −2,117 | $126.16 | $267K | 236,278 |
| 2020-11-25 | SHARP PHILLIP A Director | Sale | −645 | $127.44 | $82K | 235,633 |
| 2020-11-25 | SHARP PHILLIP A Director | Exercise or conversion · Stock Option (right to buy) | −30,000 | 0 | ||
| 2020-11-19 | MARAGANORE JOHN Chief Executive Officer | Exercise or conversion | +34,765 | $9.14 | $318K | 232,354 |
| 2020-11-19 | MARAGANORE JOHN Chief Executive Officer | Sale | −18,987 | $123.55 | $2.3M | 213,367 |
| 2020-11-19 | MARAGANORE JOHN Chief Executive Officer | Sale | −5,489 | $124.49 | $683K | 207,878 |
| 2020-11-19 | MARAGANORE JOHN Chief Executive Officer | Sale | −10,187 | $125.35 | $1.3M | 197,691 |
| 2020-11-19 | MARAGANORE JOHN Chief Executive Officer | Sale | −102 | $126.62 | $13K | 197,589 |
| 2020-11-19 | MARAGANORE JOHN Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −34,765 | 0 | ||
| 2020-09-29 | Vaishnaw Akshay President, R&D | Exercise or conversion | +971 | $42.22 | $41K | 15,090 |
| 2020-09-29 | Vaishnaw Akshay President, R&D | Sale | −971 | $140.00 | $136K | 14,119 |
| 2020-09-29 | Vaishnaw Akshay President, R&D | Exercise or conversion · Stock Option (right to buy) | −971 | 3,338 | ||
| 2020-09-09 | Greene Barry E President | Exercise or conversion | +44,530 | $9.14 | $407K | 114,873 |
| 2020-09-09 | Greene Barry E President | Sale | −14,075 | $122.66 | $1.7M | 100,798 |
| 2020-09-09 | Greene Barry E President | Sale | −27,109 | $123.39 | $3.3M | 73,689 |
| 2020-09-09 | Greene Barry E President | Sale | −3,346 | $124.38 | $416K | 70,343 |
| 2020-09-09 | Greene Barry E President | Exercise or conversion · Stock Option (right to buy) | −44,530 | 0 | ||
| 2020-08-20 | MARAGANORE JOHN Chief Executive Officer | Exercise or conversion | +34,765 | $9.14 | $318K | 232,354 |
| 2020-08-20 | MARAGANORE JOHN Chief Executive Officer | Sale | −4,775 | $135.09 | $645K | 227,579 |
Page 73 of 80 · 1,590 trades